Medical economics

GSK, Pfizer to merge consumer healthcare units

Pharmaceutical giants GlaxoSmithKline and Pfizer on Wednesday announced a merger of their consumer healthcare units that produce over-the-counter medicines.

Other

Drugmaker GSK buys US cancer firm for $1.9 bn

GlaxoSmithKline on Wednesday said it had agreed to buy US group Sierra Oncology, a specialist in medicines for rare forms of cancer, for $1.9 billion as the British drugs giant restructures.

Other

Drugmaker GSK buys US vaccine firm for up to $3.3 bn

British drugmaker GlaxoSmithKline on Tuesday snapped up US biopharmaceutical firm Affinivax for up to $3.3 billion, expanding further into vaccines before the demerger of its consumer health care arm.

Diseases, Conditions, Syndromes

Malaria vaccine: Could this 'ingredient' be the secret to success?

This ingredient is an essential component of the malaria parasite, a protein known as RPL6, which makes the parasite "visible" to a type of immune cells, the T cells, in the liver. The researchers added the protein to their ...

page 1 from 3

Joint venture

A joint venture (often abbreviated JV) is an entity formed between two or more parties to undertake economic activity together. The parties agree to create a new entity by both contributing equity, and they then share in the revenues, expenses, and control of the enterprise. The venture can be for one specific project only, or a continuing business relationship such as the Fuji Xerox joint venture. This is in contrast to a strategic alliance, which involves no equity stake by the participants, and is a much less rigid arrangement.

The phrase generally refers to the purpose of the entity and not to a type of entity. Therefore, a joint venture may be a corporation, limited liability company, partnership or other legal structure, depending on a number of considerations such as tax and tort liability.

This text uses material from Wikipedia, licensed under CC BY-SA